As Head of Equipment Development, Sarah oversees the company’s development efforts to translate the customers’ needs into innovative, reliable products. Leading a team of experts in single-use, hardware, automation and mechanical engineering, Sarah is responsible for the development, design optimization and product enhancements of the scale-X bioreactors and the NevoLine Upstream platform.
Sarah joined the parent company, Univercells, in 2018 where she played a key role in the delivery of the proof-of-concept of the NevoLine platform – the NevoLine sIPV developed under the Grand Challenges grant by the BMGF.
Sarah brings 15+ years of experiences in project management of bacterial and viral products (GSK, Vesale Pharma). Sarah holds a master’s degree in Industrial Engineer in Chemistry (HEI of the Province of Liège).